Cite
5-HT2B Receptor Antagonists Inhibit Fibrosis and Protect from RV Heart Failure.
MLA
Janssen, Wiebke, et al. “5-HT2B Receptor Antagonists Inhibit Fibrosis and Protect from RV Heart Failure.” BioMed Research International, vol. 2015, Jan. 2015, pp. 1–8. EBSCOhost, https://doi.org/10.1155/2015/438403.
APA
Janssen, W., Schymura, Y., Novoyatleva, T., Kojonazarov, B., Boehm, M., Wietelmann, A., Luitel, H., Murmann, K., Krompiec, D. R., Tretyn, A., Pullamsetti, S. S., Weissmann, N., Seeger, W., Ghofrani, H. A., & Schermuly, R. T. (2015). 5-HT2B Receptor Antagonists Inhibit Fibrosis and Protect from RV Heart Failure. BioMed Research International, 2015, 1–8. https://doi.org/10.1155/2015/438403
Chicago
Janssen, Wiebke, Yves Schymura, Tatyana Novoyatleva, Baktybek Kojonazarov, Mario Boehm, Astrid Wietelmann, Himal Luitel, et al. 2015. “5-HT2B Receptor Antagonists Inhibit Fibrosis and Protect from RV Heart Failure.” BioMed Research International 2015 (January): 1–8. doi:10.1155/2015/438403.